drugset
Drugs / Glial Neuropatch
last change Mar 2023 re-read 3 minutes ago

Glial Neuropatch

Cell therapy

Developed for
spinal cord injury
Investigated by
Akson, Neuro-Rehabilitation Center for the Treatment of Spinal Cord Injuries · Nicholls Spinal Injury Foundation · Poznan University of Medical Sciences · University College, London · Wroclaw Medical University

Trials 1

today NCT03933072 · Ph 1/2
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT03933072 Mar 2016 → Mar 2023 spinal cord injury Nicholls Spinal Injury Foundation Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Glial Neuropatch ClinicalTrials.gov intervention name — accepted as the source's own label NCT03933072 ↗
Modality Cell therapy “The final Product will consist of the aforementioned cell suspension embedded with collagen scaffold.” NCT03933072 ↗